Ignite Creation Date:
2025-12-25 @ 3:30 AM
Ignite Modification Date:
2025-12-26 @ 2:12 AM
Study NCT ID:
NCT04973605
Status:
RECRUITING
Last Update Posted:
2025-12-17
First Post:
2021-07-07
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple Myeloma
Sponsor:
BeOne Medicines
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-09-16
Start Date Type:
ACTUAL
Primary Completion Date:
2026-11
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-11
Completion Date Type:
ESTIMATED
First Submit Date:
2021-07-07
First Submit QC Date:
None
Study First Post Date:
2021-07-22
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-15
Last Update Post Date:
2025-12-17
Last Update Post Date Type:
ESTIMATED